Skin Condition in Youth: Long-Term Study
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at the long-term health of people who were diagnosed with a rare skin lymphoma (mycosis fungoides) or a related skin condition (lymphomatoid papulosis) before age 20. Researchers want to learn how these conditions affect people over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with mycosis fungoides or lymphomatoid papulosis before your 20th birthday.
- If you are under 18, a parent or legal guardian can answer the study questions for you.
- You are not eligible if you were diagnosed with these conditions after turning 20.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether ultra low-dose radiation can control specific skin lesions from mycosis fungoides (a type of lymphoma that affects the skin). It may help shrink or control targeted spots while using a lower radiation amount.
This study looks for “predictive” and “prognostic” biomarkers—measurable signs in blood or tissue—to help predict how mycosis fungoides or Sézary syndrome will behave and how patients may respond to care. It may help doctors better understand outcomes for people with these skin lymphomas.
This study looks at medical and disease details to find factors that can help predict how advanced mycosis fungoides or Sézary syndrome will behave. Your information may help doctors better estimate prognosis and plan care.
This study collects stored tissue samples (from skin or other needed procedures) from people with CTCL, Sézary syndrome, or lymphomatoid papulosis, especially when you are starting or changing treatment. It’s meant to help researchers learn more about these illnesses and may support future research.
This trial tests a treatment called photopheresis to treat early-stage mycosis fungoides, a type of skin lymphoma. It may help reduce or control skin patches or plaques that have not responded well to standard treatments.
This study collects blood, urine, and possibly small tissue samples to learn more about cutaneous T-cell lymphoma (CTCL) and either eczema or atopic dermatitis. It may help researchers better understand these skin conditions and improve future treatments.
Hear when a new Lymphomatoid Papulosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.